glucagon in retatrutide Calling a “GLP-3” is usually a quick sign that you don't understand the underlying biology. Retatrutide is a NuSH-based triple agonist—it targets GLP-1, GIP, and receptors. Only one of those retatrutide triple agonist gip glp-1

Here's what most protocols miss: IGF-1 LR3 doesn't just 'work' the moment you inject it

chromium picolinate (chromium 6 g - 15%*)

BGAT, education to optimise insulin dosing and type, and hypoglycaemia avoidance motivational programmes all improve hypoglycaemia awareness

Symptoms may include burning in the chest after eating, pain that worsens when lying down, or a bitter or acidic taste in the mouth

Why breast cancer researchers are paying attention Weight and metabolic health matter in breast cancer because excess body fat is linked to higher risk of developing breast cancer after menopause, and it may also affect recurrence, treatment tolerance, and long-term outcomes